English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

topoisomerases, we have screened cultures of actinomycetes and fungi for their ability to inhibit selectively the growth of bacteriophage TP-68 at the concentration that shows no apparent antibacterial activity against NUB3620. In the course of microbial screening, strain KYI1768 was identified to produce active metabolites. We described here production including fermentation and isolation, and biological activity of novel pyrrole-amide antitumor antibiotics, pyrronamycin A and B, produced by Streptomyces sp. The producing organism KYI 1768 was isolated from a soil sample collected in Okazaki city, Aichi prefecture, Japan and assigned to the Streptomyces sp. Fermentation was carried out at 25°C for 42 hours with appropriate aeration and agitation in 30-liter jar fermenter containing the 15 liters of culture medium consisting of glycerol 5%, dry yeast 1.5%, KH2PO4 0.05%, MgSO4-7H2O 0.05%,

Pyrronamycin A and B, Novel Antitumor Antibiotics Containing Pyrrole-amide Repeating Unit, Produced by Streptomyces sp.